Diagnostic and therapeutic appropriateness in bone and joint infections: results of a national survey

References

• Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31(Suppl 4):S131–8.
   PubMed Web of Science ®Google Scholar
• Kollef M. Appropriate empirical therapy getting it right the first time. Drugs. 2003;63(20):2157–68.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S, Ianniello F. Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey. Infez Med. 2004;12(2):90–100.
   PubMedGoogle Scholar
• Leone S, Fiore M, Felaco FM, Esposito S. Early and timely therapy: when to interrupt antibiotic therapy in nosocomial acquired pneumonia? Infez Med. 2007;15(1):16–23.
   PubMedGoogle Scholar
• Sellier E, Labarère J, Gennai S, Bal G, François P, Pavese P. Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clin Microbiol Infect Dis. 2011;30(7):887–94.
   PubMed Web of Science ®Google Scholar
• Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control. 2008;36(4):283–90.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S. Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents. 2007;29(5):494–500.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Bassetti M, Borrè S, Leoncini F, Meani E, et al. Bone joint infections committee for the italian society of infectious tropical diseases (SIMIT). Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection. 2009;37(6):478–96.
   PubMed Web of Science ®Google Scholar
• Leone S, Borrè S, Monforte AD, Mordente G, Petrosillo N, Signore A, et al. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis. 2010;14(Suppl 4):S67–7.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S. Prosthetic joint infections: microbiology, diagnosis, management and prevention. Int J Antimicrob Agents. 2008;32(4):287–93.
   PubMed Web of Science ®Google Scholar
• Segreti J. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance. Clinic Microbiol Infect. 2005;11(Suppl 3):29–35.
   PubMed Web of Science ®Google Scholar
• Kollef MH. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems. Respir Care. 2004;49(12):1530–41.
   PubMedGoogle Scholar
• Chastre J, Fagon JY. Ventilator associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903.
   PubMed Web of Science ®Google Scholar
• Iregui M, Ward S, Sherman J, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for VAP. Chest. 2002;122(1):262–8.
   PubMed Web of Science ®Google Scholar
• MacArthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L. Adequacy of early empiric antibiotic treatment and survival in severe sepsis experience from the MONARCS Trial. Clin Infect Dis. 2004;38(2):284–8.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244(5):379–86.
   PubMed Web of Science ®Google Scholar
• Behrendt G, Schneider S, Brodt HR, Just-Nübling G, Shah PM. Influence of antimicrobial treatment on mortality in septicemia. J Chemother. 1999;11(3):179–86.
   PubMed Web of Science ®Google Scholar
• Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York city hospitals. Emerg Infect Dis. 1999;5(1):9–17.
   PubMed Web of Science ®Google Scholar
• Micek ST, Lloyd AE, Ritchie DJ, Reichlev RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infections: importance of appropriate initial antibiotic treatment. Antimicrob Agents Chemother. 2005;49(4):1306–11.
   PubMed Web of Science ®Google Scholar
• Sturkenboom MC, Goettsch WG, Picelli G, Veld B, Yin D, Jong R, et al. Inappropriate initial treatment of secondary intrabdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol. 2005;60(4):438–43.
   PubMed Web of Science ®Google Scholar
• Esposito S, Esposito I, Leone S. Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections. J Antimicrob Chemother. 2012;67(11):2570–5.
   PubMed Web of Science ®Google Scholar
• Leone S, Rossi M, Bisi L, Gori A, Esposito S. Antimicrobial therapy duration: a major matter in the management of severe infections. Int J Antimicrob Agents. 2013;42(3):287–8.
   PubMed Web of Science ®Google Scholar
• Leone S, Stefani S, Venditti M, Grossi P, Colizza S, et al. Intra-abdominal infections: model of antibiotic stewardship in an era with limited antimicrobial options. Int J Antimicrob Agents. 2011;38(3):271–2.
   PubMed Web of Science ®Google Scholar
• Vallés J, Rello L, Ochagavía A, Garnacho J, Alcalá MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123(5):1615–24.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462–74.
   PubMed Web of Science ®Google Scholar
• Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29(1):60–6.
   PubMed Web of Science ®Google Scholar
• Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious disease specialist: experience with 244 patients. Clin Infect Dis. 1998;27(3):478–86.
   PubMed Web of Science ®Google Scholar
• Borer A, Gilad J, Meydan N, Schlaeffer P, Riesenberg K, Schlaeffer F. Impact of regular attendance by infectious disease specialists on the management of hospitalized adults with community-acquired febrile syndromes. Clin Microbiol Infect. 2004;10(10):911–6.
   PubMed Web of Science ®Google Scholar
• Nathwani D, Davey P, France AJ, Phillips G, Orange G, Parratt D. Impact of an infection consultation service for bacteraemia on clinical management and use of resources. QJM. 1996;89(10):789–97.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S. Management of severe bacterial infections. Expert Rev Anti Infect Ther. 2005;3(4):593–600.
   PubMedGoogle Scholar
• Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36(9):1157–61.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S, Ianniello F, Fiore M, Russo M, et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study. J Chemother. 2007;19(4):417–22.
   PubMed Web of Science ®Google Scholar
• Esposito S, Leone S, Noviello S, Ianniello F, Russo M, Foti G, et al. Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study. J Chemother. 2009;21(2):193–8.
   PubMed Web of Science ®Google Scholar
• Bulla F, Filippini P. Prosthetic joint infections by multi-drug resistant bacteria. Infez Med. 2010;18(1):5–11.
   PubMedGoogle Scholar